EluNIR-PERL is Medinol’s most recent advancement in coronary stent technology. This seventh-generation stent features a unique stent design which utilizes a distinctive CoCr framework composed of struts with varying widths and integrates radiopaque markers into its structure.
Furthermore, the stent features a specialized radiopaque enhanced metal spring tip designed for navigating through complex anatomies. These design elements are intended to equip physicians with precise positional information, facilitating accurate stent placement during PCI procedures.

PERL Overview tiny2

Key Features

  • Enhanced Deliverability and Crossability

    Superior deliverability with a unique and flexible metal spring tip
  • Outstanding Surface Integrity

    Elastomeric coating and outstanding surface integrity providing a uniform rapamycin analogue drug elution
  • Unparalleled Visibility

    Reinforced radiopaque tip and stent markers for accurate delivery and stent positioning
  • Optimal Scaffolding and Conformability

    Unique stent design providing optimal flexibility and radial strength resulting in superior scaffolding and vessel conformability

Clinical Overview



Target Lesion Failure

1-yr BIONICS trial results



Stent Thrombosis (Definite+Probable)

1-yr BIONICS trial results



Target Vessel Myocardial Infraction

1-yr BIONICS trial results


Kaplan Medical Center Heart Institute, Rehovot, Israel
Prof. Michael Jonas
Director of Cardiac Catheterization and Structural Heart Disease Services
Wolfson Medical Center, Holon, Israel
Prof. Haim Danenberg
Head of Interventional Cardiology